PUBLISHER: The Business Research Company | PRODUCT CODE: 1829906
PUBLISHER: The Business Research Company | PRODUCT CODE: 1829906
Heart closure devices are sophisticated medical instruments designed to close holes or openings in the heart, often resulting from congenital defects or surgical procedures. These devices are used to treat conditions such as atrial septal defects (ASD), patent foramen ovale (PFO), and other structural heart issues. Typically, they are delivered through catheter-based procedures, providing a safer alternative to open-heart surgery.
The main types of heart closure devices include atrial septal defect (ASD) closure devices, ventricular septal defect (VSD) closure devices, patent foramen ovale (PFO) closure devices, left atrial appendage (LAA) closure devices, and others. ASD closure devices are implants used to seal abnormal openings in the septum between the heart's upper chambers and are usually deployed through minimally invasive catheter-based procedures. These devices are commonly made from materials such as nitinol, stainless steel, and other substances. Delivery methods include both transcatheter and surgical approaches, and these devices are utilized in various healthcare settings such as hospitals, ambulatory surgical centers (ASCs), and cardiac catheterization laboratories.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The heart closure devices market research report is one of a series of new reports from The Business Research Company that provides heart closure devices market statistics, including the heart closure devices industry global market size, regional shares, competitors with the heart closure devices market share, detailed heart closure devices market segments, market trends, and opportunities, and any further data you may need to thrive in the heart closure devices industry. This heart closure devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The heart closure devices market size has grown rapidly in recent years. It will grow from $2.77 billion in 2024 to $3.08 billion in 2025 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to increasing awareness among healthcare providers, increasing device approvals by authorities, increasing favorable reimbursement policies, increasing cardiovascular diseases, and a growing geriatric population.
The heart closure devices market size is expected to see rapid growth in the next few years. It will grow to $4.86 billion in 2029 at a compound annual growth rate (CAGR) of 12.0%. The growth in the forecast period can be attributed to the increasing incidence of congenital heart defects, rising adoption of MRI procedures, increasing number of heart strokes, increasing incidence of atrial fibrillation, and rising preference for minimally invasive procedures. Major trends in the forecast period include the integration of multi-functional devices, technological advancements, innovation in materials and design, the integration of imaging technologies, and innovation in bioresorbable materials.
The forecast of 12.0% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on atrial septal defect occluders and nitinol mesh frameworks, sourced from key regions such as Italy and the Netherlands, which could lead to postponed congenital heart defect repairs and higher interventional cardiology costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing incidence of cardiovascular diseases (CVDs) is expected to drive the growth of the heart closure devices market. The rise in CVDs is attributed to factors such as aging, unhealthy lifestyle choices, genetic predisposition, and a higher prevalence of risk factors such as hypertension, diabetes, and obesity. Heart closure devices play a crucial role in minimizing complications caused by congenital heart defects by closing abnormal openings in the heart with minimal invasiveness, improving blood flow, and preventing further health issues. For instance, in May 2024, the Singapore Heart Foundation reported that cardiovascular diseases accounted for 26,885 deaths in 2023, with ischemic heart disease alone causing 5,302 deaths, showing a slight increase from the previous year. This growing incidence of cardiovascular diseases is driving the demand for heart closure devices.
Companies in the heart closure devices market are focusing on innovative solutions, such as patent foramen ovale (PFO) occlusion systems, to improve patient outcomes and reduce complications during procedures. PFO occlusion systems are designed to close a persistent hole between the right and left atria, which should have closed after birth but remains open in some individuals. For example, in September 2022, Abbott Laboratories launched the Amplatzer Talisman PFO Occlusion System, specifically for individuals with PFO, especially those who have experienced a stroke. The system features a pre-attached occluder for simplified procedures, a versatile 30mm size for better adaptability, and a fully recapturable design to ensure effective closure of the PFO and reduce the risk of future strokes.
In November 2023, Johnson & Johnson MedTech, a US-based medical device company, acquired Laminar Inc. for $400 million. This acquisition enhances Johnson & Johnson MedTech's product offerings in cardiac arrhythmia treatment, strengthens its market presence in left atrial appendage elimination devices, and enables innovation in stroke prevention solutions for patients with non-valvular atrial fibrillation. Laminar Inc. is a US-based manufacturer specializing in heart closure devices.
Major players in the heart closure devices market are Abbott Laboratories, Medtronic plc, Boston Scientific Corp., Lepu Medical Technology Ltd., Terumo Corporation, Edwards Lifesciences, Teleflex Incorporated, Merit Medical Systems Inc., Cordis Corporation, AtriCure Inc., Lifetech Scientific Corp., Sahajanand Medical Technologies, W. L. Gore And Associates Inc., Occlutech GmbH, NMT Medical Inc., Sorin Group Italia S.p.A., Vivasure Medical Limited, B Braun Interventional Systems, HeartStitch Inc., and MicroPort Scientific Corporation.
North America was the largest region in the heart closure devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in heart closure devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the heart closure devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The heart closure devices market consists of sales of septal occluders, embolic protection devices, valvular closure devices, balloon occlusion devices, and transcatheter closure devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Heart Closure Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on heart closure devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for heart closure devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The heart closure devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.